Giuseppe Procopio
Giuseppe Procopio is the Head of Genitourinary Medical Oncology at the IRCCS National Cancer Institute in Milan, Italy. He is a recognized expert in the treatment of prostate cancer, particularly in the development and application of targeted therapies. Procopio has been at the forefront of introducing novel treatments, such as radioligands, which offer new hope for advanced prostate cancer patients, aiming to enhance both survival rates and quality of life.
Not in the pool (under ¢1).
Recent news mentions
Giuseppe Procopio explained the PSA test and its significance in prostate cancer detection.
Che cos'è il tumore alla prostata: test del Psa, terapie e sintomi
Italy· 2025-11-25
Giuseppe Procopio is the director of the Prostate and Genitourinary Medical Oncology Program at the National Cancer Institute in Milan.
Tumore della vescica, così migliorano le prospettive (anche di guarigione) per migliaia di pazientiItaly· 2025-10-19
Giuseppe Procopio is the director of the Prostate Program and Medical Oncology at the National Cancer Institute of Milan.
Prostata, a chi serve il test del Psa? Chi deve iniziare a 40 anni?E cosa si deve fare se è alto?Italy· 2025-06-22
Giuseppe Procopio is responsible for Medical Oncology at the Genitourinary Foundation IRCCS National Cancer Institute in Milan.
Tumore alla prostata, ecco il primo radioligando: diagnosi e terapia in un solo farmacoItaly· 2025-02-24